Literature DB >> 3654486

Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children.

J M Launay1, C Bursztejn, P Ferrari, C Dreux, A Braconnier, E Zarifian, S Lancrenon, J Fermanian.   

Abstract

In a group of 22 autistic children aged 5 to 16 years and a group of normal controls matched for age and sex, catecholamines metabolism was investigated in plasma, platelets, and urine. This investigation was part of a research project in which several biological parameters (including serotonin) were explored simultaneously in the same children. In the autistic group, epinephrine and norepinephrine were significantly elevated in plasma, while epinephrin, norepinephrine, and dopamine were significantly lower in isolated platelets. No significant difference was found between the two groups for the urinary excretion of epinephrine, norepinephrine, dopamine, DOPAC, and MHPG. Other differences between the two groups in the statistical correlations of several biochemical parameters also suggest abnormalities of bioamine metabolism in the platelets of autistic children.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3654486     DOI: 10.1007/bf01487064

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  28 in total

Review 1.  Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety.

Authors:  D E Redmond; Y H Huang
Journal:  Life Sci       Date:  1979-12-24       Impact factor: 5.037

2.  Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity.

Authors:  G Sedvall; B Fyrö; B Gullberg; H Nybäck; F A Wiesel; B Wode-Helgodt
Journal:  Br J Psychiatry       Date:  1980-04       Impact factor: 9.319

3.  Cerebrospinal fluid, plasma, and urinary MHPG in children.

Authors:  J G Young; D J Cohen; M E Kavanagh; H D Landis; B A Shaywitz; J W Maas
Journal:  Life Sci       Date:  1981-06-22       Impact factor: 5.037

4.  Maximal packet size for serotonin in storage vesicles of intact human platelets.

Authors:  J L Costa; H Stark; B Shafer; L Corash; M A Smith; D L Murphy
Journal:  Life Sci       Date:  1978-11-27       Impact factor: 5.037

5.  Decreased urinary free catecholamines in childhood autism.

Authors:  J G Young; D J Cohen; S L Brown; B K Caparulo
Journal:  J Am Acad Child Psychiatry       Date:  1978

6.  Blood platelet monoamine oxidase activity in schizophrenic children and their families. A preliminary study.

Authors:  M Campbell; E Friedman; W H Green; A M Small; E I Burdock
Journal:  Neuropsychobiology       Date:  1976       Impact factor: 2.328

7.  Radioenzymatic assay of platelet serotonin, dopamine and norepinephrine in subjects with normal and increased serotonin production.

Authors:  J M Feldman; J A Davis
Journal:  Clin Chim Acta       Date:  1981-02-05       Impact factor: 3.786

8.  Investigations of catecholamine metabolism using high-performance liquid chromatography: analytical methodology and clinical applications.

Authors:  A M Krstulović
Journal:  J Chromatogr       Date:  1982-04-16

9.  [Modifications in urinary homovanillic acid after ingestion of vitamin B6; functional study in autistic children (author's transl)].

Authors:  G Lelord; E Callaway; J P Muh; J C Arlot; D Sauvage; B Garreau; J Domenech
Journal:  Rev Neurol (Paris)       Date:  1978-12       Impact factor: 2.607

10.  Decreased 24-hour urinary MHPG in childhood autism.

Authors:  J G Young; D J Cohen; B K Caparulo; S L Brown; J W Maas
Journal:  Am J Psychiatry       Date:  1979-08       Impact factor: 18.112

View more
  24 in total

1.  Brief report: a double-blind study of naltrexone in infantile autism.

Authors:  M Leboyer; M P Bouvard; J M Launay; F Tabuteau; D Waller; M Dugas; B Kerdelhue; P Lensing; J Panksepp
Journal:  J Autism Dev Disord       Date:  1992-06

2.  Pupil and salivary indicators of autonomic dysfunction in autism spectrum disorder.

Authors:  Christa J Anderson; John Colombo; Kathryn E Unruh
Journal:  Dev Psychobiol       Date:  2012-05-29       Impact factor: 3.038

Review 3.  Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Authors:  Logan K Wink; Martin H Plawecki; Craig A Erickson; Kimberly A Stigler; Christopher J McDougle
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

4.  Brief report: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism.

Authors:  I Nir; D Meir; N Zilber; H Knobler; J Hadjez; Y Lerner
Journal:  J Autism Dev Disord       Date:  1995-12

5.  Investigation of whole blood and urine monoamines in autism.

Authors:  Josiane Hérault; Joëlle Martineau; Anne Perrot-Beaugerie; Jacqueline Jouve; Hervé Tournade; Catherine Barthelemy; Gilbert Lelord; Jean-Pierre Muh
Journal:  Eur Child Adolesc Psychiatry       Date:  1993-10       Impact factor: 4.785

Review 6.  Medication treatment in subjects with autistic spectrum disorders.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

7.  Effect of propranolol on functional connectivity in autism spectrum disorder--a pilot study.

Authors:  Ananth Narayanan; Catherine A White; Sanjida Saklayen; Mary J Scaduto; Allen L Carpenter; Amir Abduljalil; Petra Schmalbrock; David Q Beversdorf
Journal:  Brain Imaging Behav       Date:  2010-06       Impact factor: 3.978

8.  Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry.

Authors:  Regina Taurines; Edward Dudley; Alexander C Conner; Julia Grassl; Thomas Jans; Frank Guderian; Claudia Mehler-Wex; Andreas Warnke; Manfred Gerlach; Johannes Thome
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-09-27       Impact factor: 5.270

9.  Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene.

Authors:  Lea K Davis; Heather C Hazlett; Amy L Librant; Peggy Nopoulos; Val C Sheffield; Joesph Piven; Thomas H Wassink
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

Review 10.  Antipsychotics in the treatment of autism.

Authors:  David J Posey; Kimberly A Stigler; Craig A Erickson; Christopher J McDougle
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.